logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
26/09/2025
Changfeng Pharmaceutical plans to raise 607.67 million Hong Kong dollars through an IPO in Hong Kong, planning to sell 41.2 million shares at a price of 14.75 Hong Kong dollars per share. Changfeng Pharmaceutical expects the shares to start trading on the Hong Kong Stock Exchange on October 8th.
Latest
3 m ago
The Bank of Mexico once again cuts the benchmark interest rate to 7.50%
3 m ago
Citigroup: US President Trump's proposal to impose tariffs on drug imports is expected to have limited impact on Chinese pharmaceutical and biotechnology companies.
3 m ago
Citibank: U.S. President Trump's proposal to impose tariffs on imported drugs is expected to have limited impact on Chinese pharmaceutical and biotech companies.
4 m ago
Citigroup Research has raised UBS Technology's target price from HK$121.00 to HK$170.00.
4 m ago
Citigroup Research has raised Ubibright's target price from HK$121.00 to HK$170.00.
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.